SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-217120
Filing Date
2020-08-12
Accepted
2020-08-12 09:02:12
Documents
36
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d914242d10q.htm 10-Q 231467
2 EX-31.1 d914242dex311.htm EX-31.1 6476
3 EX-31.2 d914242dex312.htm EX-31.2 6479
4 EX-32.1 d914242dex321.htm EX-32.1 3002
5 EX-32.2 d914242dex322.htm EX-32.2 3009
  Complete submission text file 0001193125-20-217120.txt   1447403

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inti-20200630.xml EX-101.INS 158396
7 XBRL TAXONOMY EXTENSION SCHEMA inti-20200630.xsd EX-101.SCH 19084
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inti-20200630_cal.xml EX-101.CAL 15972
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inti-20200630_def.xml EX-101.DEF 111067
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inti-20200630_lab.xml EX-101.LAB 165641
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inti-20200630_pre.xml EX-101.PRE 138304
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 201094293
SIC: 8731 Services-Commercial Physical & Biological Research